Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system.

Szczegóły
Abstrakt

Tytuł:: Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system.
Autorzy:: Miles RC; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Lehman CD; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Mercaldo SF; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Tamimi RM; Channing Institute, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Dontchos BN; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Narayan AK; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Źródło:: Cancer [Cancer] 2019 Dec 01; Vol. 125 (23), pp. 4158-4163. Date of Electronic Publication: 2019 Aug 08.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: <2005- >: Hoboken, NJ : Wiley
Original Publication: New York [etc.] Published for the American Cancer Society by J. Wiley [etc.]
MeSH Terms:: Behavioral Risk Factor Surveillance System*
Breast Neoplasms/*epidemiology
Breast Neoplasms/*etiology
Obesity/*epidemiology
Aged ; Cross-Sectional Studies ; Early Detection of Cancer ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
References:: DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52-62.
Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2001. National Cancer Institute; 2004.
US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-726, W-236.
Alexandraki I, Mooradian AD. Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc. 2010;102:206-218.
Sarma EA. Barriers to screening mammography. Health Psychol Rev. 2015;9:42-62.
Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Womens Health Gend Based Med. 2001;10:463-470.
Bussiere C, Sicsic J, Pelletier-Fleury N. The effects of obesity and mobility disability in access to breast and cervical cancer screening in France: results from the National Health and Disability Survey. PLoS One. 2014;9:e104901.
Cohen SS, Signorello LB, Gammon MD, Blot WJ. Obesity and recent mammography use among black and white women in the Southern Community Cohort Study (United States). Cancer Causes Control. 2007;18:765-773.
Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med. 2004;19:324-331.
Ferrante JM, Chen PH, Crabtree BF, Wartenberg D. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med. 2007;32:525-531.
Zhu K, Wu H, Jatoi I, Potter J, Shriver C. Body mass index and use of mammography screening in the United States. Prev Med. 2006;42:381-385.
Sebastiani F, Cortesi L, Sant M, et al. Increased incidence of breast cancer in postmenopausal women with high body mass index at the Modena Screening Program. J Breast Cancer. 2016;19:283-291.
Boyd NF, Martin LJ, Sun L, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2086-2092.
Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women's Health Initiative randomized clinical trials. JAMA Oncol. 2015;1:611-621.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer; 2001.
Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13:325-332.
Littman AJ, Koepsell TD, Forsberg CW, Boyko EJ, Yancy WS Jr. Preventive care in relation to obesity: an analysis of a large, national survey. Am J Prev Med. 2011;41:465-472.
Hall HI, Coates RJ, Uhler RJ, et al. Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer. 1999;82:23-27.
Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002;98:279-283.
Maehle BO, Tretli S, Skjaerven R, Thorsen T. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status. Breast Cancer Res Treat. 2001;68:159-169.
Reeves MJ, Newcomb PA, Remington PL, Marcus PM, MacKenzie WR. Body mass and breast cancer. Relationship between method of detection and stage of disease. Cancer. 1996;77:301-307.
Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer. 1992;65:922-926.
Torgerson D. Risk factors for breast cancer. Socioeconomic differences might be explained by body mass. BMJ. 1994;309:1662.
Poikonen P, Blomqvist C, Joensuu H. Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area. Acta Oncol. 2001;40:67-71.
Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15:556-565.
Lyman GH. Weight-based chemotherapy dosing in obese patients with cancer: back to the future. J Oncol Pract. 2012;8:e62-e64.
Duong MN, Cleret A, Matera EL, et al. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. Breast Cancer Res. 2015;17:57.
Jeevan R, Browne JP, Pereira J, et al. Socioeconomic deprivation and inpatient complication rates following mastectomy and breast reconstruction surgery. Br J Surg. 2015;102:1064-1070.
Jiralerspong S, Goodwin PJ. Obesity and breast cancer prognosis: evidence, challenges, and opportunities. J Clin Oncol. 2016;34:4203-4216.
Njor SH, von Euler-Chelpin M, Tjonneland A, Vejborg I, Lynge E. Body weight and sensitivity of screening mammography. Eur J Cancer. 2016;60:93-100.
Gayde C, Goolam I, Bangash HK, Tresham J, Fritschi L, Wylie E. Outcome of mammography in women with large breasts. Breast. 2012;21:493-498.
Destounis S, Newell M, Pinsky R. Breast imaging and intervention in the overweight and obese patient. AJR Am J Roentgenol. 2011;196:296-302.
Beeken RJ, Wilson R, McDonald L, Wardle J. Body mass index and cancer screening: findings from the English Longitudinal Study of Ageing. J Med Screen. 2014;21:76-81.
Fitzgibbon ML, Blackman LR, Avellone ME. The relationship between body image discrepancy and body mass index across ethnic groups. Obes Res. 2000;8:582-589.
Stommel M, Schoenborn CA. Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006. BMC Public Health. 2009;9:421.
Contributed Indexing:: Keywords: breast cancer; breast cancer following guidelines (all); mammography; obesity; screening
Entry Date(s):: Date Created: 20190809 Date Completed: 20200603 Latest Revision: 20200603
Update Code:: 20240104
DOI:: 10.1002/cncr.32430
PMID:: 31393609
: Czasopismo naukowe

Full Text Finder

Background: Postmenopausal obese women demonstrate an elevated breast cancer risk and experience increased breast cancer morbidity and mortality compared with women with a normal body mass index (BMI). However, to the authors' knowledge, prior studies have yielded inconclusive results regarding the effects of obesity on mammography screening adherence. Using national cross-sectional survey data, the objective of the current study was to assess the current association between increasing BMI and use of mammography screening.
Methods: Cross-sectional survey data from the 2016 Behavioral Risk Factor Surveillance System, a state-based national telephone survey of noninstitutionalized adults in the United States, was used to identify the association between mammography screening use and increasing incremental BMI categories, including normal (18.5-24.9 kg/m 2 ), overweight (25-29.9 kg/m 2 ), obese class I (30-34.9 kg/m 2 ), obese class II (35-39.9 kg/m 2 ), and obese class III (>40 kg/m 2 ), with adjustments for potential confounders. A multivariable logistic regression model was used to evaluate the effect of each BMI category on self-reported mammography use, using unadjusted and adjusted odds ratios. Effect modification by race/ethnicity was determined by testing interaction terms using Wald tests.
Results: Of 116,343 survey respondents, 33.5% (38,984 respondents) had a normal BMI, 32.6% (37,969 respondents) were overweight, 19.3% (22,416 respondents) were classified as obese class I, 8.4% (9791 respondents) were classified as obese class II, and 6.2% (7183 respondents) were classified as obese class III. There was no statistically significant difference (P < .05) observed with regard to mammography use between women with a normal BMI and obese women from each obese class (classes I-III) when compared individually. There also was no evidence of effect modification by race (P = .53).
Conclusions: In contrast to prior reports, the results of the current study demonstrated no association between obesity and adherence to screening mammography. These findings may relate to the increasing social acceptance of obesity among women from all racial/ethnic groups and the removal of weight-related facility-level barriers over time.
(© 2019 American Cancer Society.)

Informacja